应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CMS CMS能源
盘后交易 06-25 17:13:53 EDT
77.10
+0.61
+0.80%
盘后
77.10
+0.00
0.00%
17:02 EDT
最高
77.72
最低
75.56
成交量
398.72万
今开
75.56
昨收
76.49
日振幅
2.82%
总市值
237.47亿
流通市值
232.84亿
总股本
3.08亿
成交额
3.08亿
换手率
1.32%
流通股本
3.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
CMS能源任命Sri Maddipati为首席财务官,Chris Fultz为电力供应业务总裁
美股速递 · 06-04
CMS能源任命Sri Maddipati为首席财务官,Chris Fultz为电力供应业务总裁
跨国巨头“瘦身”换挡,豪赌百亿美元新药胜算几何?
21世纪经济报道 · 05-27
跨国巨头“瘦身”换挡,豪赌百亿美元新药胜算几何?
康哲药业(00867):创新药高选择性TYK2抑制剂CMS-D001获得溃疡性结肠炎适应症和克罗恩病适应症药物临床试验批准通知书
智通财经 · 05-26
康哲药业(00867):创新药高选择性TYK2抑制剂CMS-D001获得溃疡性结肠炎适应症和克罗恩病适应症药物临床试验批准通知书
Ceribell上调2026年营收预期至1.12-1.16亿美元,谵妄监测新获CMS附加支付支持
环球市场播报 · 05-13
Ceribell上调2026年营收预期至1.12-1.16亿美元,谵妄监测新获CMS附加支付支持
Consumers Energy提交第一抵押权债券发行申请,规模暂未披露
投资观察 · 04-30
Consumers Energy提交第一抵押权债券发行申请,规模暂未披露
国产电子后视镜技术获关键突破 车规级应用加速落地
中金财经 · 04-30
国产电子后视镜技术获关键突破 车规级应用加速落地
CMS能源:每新增1吉瓦大型负荷将带来20亿至50亿美元资本机遇
美股速递 · 04-28
CMS能源:每新增1吉瓦大型负荷将带来20亿至50亿美元资本机遇
新型气象站助力CMS能源提升抢修效率、强化安全保障并降低风暴成本
美股速递 · 04-21
新型气象站助力CMS能源提升抢修效率、强化安全保障并降低风暴成本
财报前瞻|CMS能源本季度营收预计增12.04%,机构观点偏正面
财报Agent · 04-21
财报前瞻|CMS能源本季度营收预计增12.04%,机构观点偏正面
Anthropic最强模型曝光,性能实现“代际跃迁”,全面碾压Opus!
华尔街见闻 · 03-27
Anthropic最强模型曝光,性能实现“代际跃迁”,全面碾压Opus!
康哲药业:INHBE小核酸药物CMS-D008临床试验获批治疗超重或肥胖
财经网 · 03-06
康哲药业:INHBE小核酸药物CMS-D008临床试验获批治疗超重或肥胖
康哲药业(00867):自主研发创新药INHBE小核酸药物CMS-D008获得超重或肥胖适应症药物临床试验批准通知书
智通财经 · 03-04
康哲药业(00867):自主研发创新药INHBE小核酸药物CMS-D008获得超重或肥胖适应症药物临床试验批准通知书
CMS暂停Elevance医保优势处方药计划的新成员注册
环球市场播报 · 03-02
CMS暂停Elevance医保优势处方药计划的新成员注册
数字解读可靠性路线图:客户投资驱动2025年实现2700项电力可靠性升级
美股速递 · 02-18
数字解读可靠性路线图:客户投资驱动2025年实现2700项电力可靠性升级
CMS能源:依据新招股说明书,约4.923亿美元总发行价股票仍可供发售——SEC文件披露
美股速递 · 02-12
CMS能源:依据新招股说明书,约4.923亿美元总发行价股票仍可供发售——SEC文件披露
CMS能源预计精选大型多年经济发展项目将于2026年启动加速——电话会议透露
美股速递 · 02-05
CMS能源预计精选大型多年经济发展项目将于2026年启动加速——电话会议透露
CMS能源大幅上调发电投资计划 较原方案增加约25亿美元
美股速递 · 02-05
CMS能源大幅上调发电投资计划 较原方案增加约25亿美元
CMS能源第四季度调整后每股收益0.95美元 超出IBES预期0.94美元
投资观察 · 02-05
CMS能源第四季度调整后每股收益0.95美元 超出IBES预期0.94美元
康哲药业(00867)自主研发的创新药CMS-D017胶囊获得补体参与介导的肾脏疾病适应症药物临床试验批准通知书
智通财经 · 02-03
康哲药业(00867)自主研发的创新药CMS-D017胶囊获得补体参与介导的肾脏疾病适应症药物临床试验批准通知书
康哲药业(00867):创新药补体因子B抑制剂CMS-D017 获得阵发性睡眠性血红蛋白尿症适应症药物临床试验批准通知书
智通财经 · 01-30
康哲药业(00867):创新药补体因子B抑制剂CMS-D017 获得阵发性睡眠性血红蛋白尿症适应症药物临床试验批准通知书
加载更多
公司概况
公司名称:
CMS能源
所属市场:
NYSE
上市日期:
--
主营业务:
CMS Energy Corporation于1987年在密歇根州成立,是一家主要在该州内运营的能源公司。它是多家子公司的母公司控股公司,包括电力和燃气公用事业公司Consumers Energy,以及作为美国独立电力生产商和营销商运营的NorthStar Clean Energy。Consumers Energy为住宅、商业和工业客户提供电力和天然气服务,NorthStar Clean Energy则开发、运营和营销可再生能源和其他独立发电项目。CMS能源通过三个主要业务部门管理其运营:电力公用事业、燃气公用事业和NorthStar清洁能源,代表非公用事业运营和投资。消费者能源在CMS能源的总资产、收入、营业收入中占比较大。
发行价格:
--
{"stockData":{"symbol":"CMS","market":"US","secType":"STK","nameCN":"CMS能源","latestPrice":77.1,"timestamp":1782417600000,"preClose":76.49,"halted":0,"volume":3987237,"hourTrading":{"tag":"盘后","latestPrice":77.1,"preClose":77.1,"latestTime":"17:02 EDT","volume":542448,"amount":41822740.8,"timestamp":1782421336686,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00797489867956595,"floatShares":302000000,"shares":307996655,"eps":3.619946,"marketStatus":"盘后交易","change":0.61,"latestTime":"06-25 17:13:53 EDT","open":75.56,"high":77.72,"low":75.56,"amount":307604090.54166,"amplitude":0.028239,"askPrice":78.6,"askSize":25,"bidPrice":75.61,"bidSize":26,"shortable":3,"etf":0,"ttmEps":3.619946,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782432000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":-722977200000,"exchange":"NYSE","adjPreClose":76.49,"dividendRate":0.02849,"preHourTrading":{"tag":"盘前","latestPrice":75.58,"preClose":76.47,"latestTime":"09:29 EDT","volume":117,"amount":8855.659800000001,"timestamp":1782394199999,"change":-0.89,"changeRate":-0.011639,"amplitude":0.0119},"postHourTrading":{"tag":"盘后","latestPrice":77.1,"preClose":77.1,"latestTime":"17:02 EDT","volume":542448,"amount":41822740.8,"timestamp":1782421336686,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.089225,"impliedVol":0.2817,"impliedVolPercentile":0.9402},"requestUrl":"/m/hq/s/CMS","defaultTab":"news","newsList":[{"id":"1164728520","title":"CMS能源任命Sri Maddipati为首席财务官,Chris Fultz为电力供应业务总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1164728520","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164728520?lang=zh_cn&edition=full","pubTime":"2026-06-04 01:30","pubTimestamp":1780507827,"startTime":"0","endTime":"0","summary":"CMS能源公司宣布了其高级管理团队的重要人事任命。Sri Maddipati将出任公司首席财务官一职,而Chris Fultz则被任命为电力供应业务总裁。\n这两项任命标志着该公司在战略领导层上的关键布局。Maddipati将负责领导公司的整体财务战略、规划及报告工作。与此同时,Fultz将执掌电力供应业务部门,专注于该核心业务的运营与发展。\n公司此举旨在强化其管理团队,以应对不断变化的能源市场格局,并推动未来的可持续增长。新的领导层组合预计将为公司的财务健康与核心业务运营带来新的视角与动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2500361329.USD","CMS","LU2346227817.USD","LU0738911758.USD","LU1894683348.USD","BK4208","BK4588","LU0545039389.USD","LU1003077747.HKD","LU0949170772.SGD","LU0661504455.SGD","BK4585","LU2637428348.USD","LU0553294199.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638450323","title":"跨国巨头“瘦身”换挡,豪赌百亿美元新药胜算几何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2638450323","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638450323?lang=zh_cn&edition=full","pubTime":"2026-05-27 16:59","pubTimestamp":1779872340,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛4500个岗位,约10%的全球员工规模,1700亿日元(约10.7亿美元)的战略重组成本——这是日本制药巨头武田制药近日交出的一份“瘦身”成绩单。按照武田自己的说法,这不是撤退,而是转型。根据一项被称为“转型计划”的重组行动,此次裁员旨在集中企业职能、精简管理层级,并寄望于技术手段实现流程自动化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605273751361640.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605273751361640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU2637428348.USD","BK1574","LU0545039389.USD","LU0738911758.USD","LU0553294199.USD","LU1003077747.HKD","IPOS","BK1191","LU2500361329.USD","LU1894683264.USD","LU0661504455.SGD","01477","LU1894683348.USD","LU0949170772.SGD","LU2346227817.USD","BK4588","CMS","BK4208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638568587","title":"康哲药业(00867):创新药高选择性TYK2抑制剂CMS-D001获得溃疡性结肠炎适应症和克罗恩病适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2638568587","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638568587?lang=zh_cn&edition=full","pubTime":"2026-05-26 06:30","pubTimestamp":1779748246,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 发布公告,于2026年5月22日,创新药CMS-D001片获得中国国家药品监督管理局签发的药物临床试验批准通知书,于5月25日收到药物临床试验批准通知书。NMPA同意本集团开展临床试验以评价CMS-D001治疗溃疡性结肠炎适应症和克罗恩病适应症的安全性和有效性。目前,CMS-D001健康受试者I期研究已完成,银屑病和特应性皮炎的Ⅱ期临床试验正在开展中,首例受试者已入组。CMS-D001未来还拟开发用于治疗系统性红斑狼疮等自身免疫病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0949170772.SGD","159992","06978","IE00BVYPNP33.GBP","LU2637428348.USD","BK1191","BK1593","LU2500361329.USD","00867","LU2346227817.USD","SG9999015978.USD","SG9999004220.SGD","IE00BYV24P56.USD","BK4208","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","LU1894683264.USD","BK4588","LU0738911758.USD","LU0545039389.USD","SG9999015945.SGD","BK4585","LU0661504455.SGD","LU1003077747.HKD","IE00BVYPNQ40.USD","LU0553294199.USD","BK1574","LU1894683348.USD","SG9999015986.USD","CMS","IE00BGHQDM52.EUR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635440902","title":"Ceribell上调2026年营收预期至1.12-1.16亿美元,谵妄监测新获CMS附加支付支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2635440902","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635440902?lang=zh_cn&edition=full","pubTime":"2026-05-13 03:15","pubTimestamp":1778613300,"startTime":"0","endTime":"0","summary":"脑电监测技术公司Ceribell周一公布一季度财报,同时将全年营收预期上调至1.12亿至1.16亿美元。CMS近期提出的NTAP新规若获通过,其谵妄监测方案单例患者最高可获约2171美元的额外支付。 CMS在其2027财年住院病人前瞻支付系统拟议规则中,提出对Ceribell谵妄监测方案给予最高约2171美元每例患者的NTAP附加支付,最终规则预计于2026年8月公布,若获通过将于10月1日生效。季末现金及有价证券约1.41亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-13/doc-inhxspmw1220344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CMS","CBLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167075292","title":"Consumers Energy提交第一抵押权债券发行申请,规模暂未披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1167075292","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167075292?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:55","pubTimestamp":1777560925,"startTime":"0","endTime":"0","summary":"4月30日——CMS能源旗下Consumers Energy公司已正式提交第一抵押权债券的发行申请,本次发行将分为一个部分进行。不过,该公司并未在申报文件中披露此次债券发行的具体规模。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0949170772.SGD","LU2500361329.USD","BK4588","LU0738911758.USD","LU1894683264.USD","LU1003077747.HKD","CMS","LU1894683348.USD","BK4585","LU2346227817.USD","BK4208","LU0553294199.USD","LU0661504455.SGD","LU2637428348.USD","LU0545039389.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634768","title":"国产电子后视镜技术获关键突破 车规级应用加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634768","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631634768?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:07","pubTimestamp":1777550827,"startTime":"0","endTime":"0","summary":"随着智能网联汽车产业快速发展,车载视觉系统对行车安全的支撑作用愈发关键。记者从行业获悉,我国企业在电子后视镜核心技术上取得新进展,相关产品已从示范应用迈向车规级规模化落地,逐步打破传统光学后视镜的视野与场景局限,推动车载视觉安全向深度智能化升级。 上海傲目智能科技推出的“EYEX”电子后视镜系统实现核心性能突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260430/32195001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0738911758.USD","LU1894683264.USD","LU2500361329.USD","BK4208","LU0545039389.USD","LU0553294199.USD","LU2346227817.USD","LU1003077747.HKD","LU1894683348.USD","LU0949170772.SGD","LU2637428348.USD","BK4585","BK4588","LU0661504455.SGD","CMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179832524","title":"CMS能源:每新增1吉瓦大型负荷将带来20亿至50亿美元资本机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1179832524","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179832524?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:21","pubTimestamp":1777386111,"startTime":"0","endTime":"0","summary":"在最新电话会议中,CMS能源公司披露了其对于新兴市场机遇的评估。根据公司高层分享的数据,电力基础设施领域正迎来显著增长窗口。\n具体而言,针对每新增1吉瓦规模的大型工业负荷,该公司预测将产生20亿至50亿美元的资本投资机会。这一测算凸显了能源转型背景下,电网升级与扩容所需的巨额资金投入。\n此类资本机遇主要涉及输电线路建设、变电站扩建以及智能化电网管理系统等核心领域。随着制造业回流与数据中心需求激增,大型电力用户对稳定供电的需求正推动相关基础设施投资加速。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","LU0553294199.USD","LU0661504455.SGD","LU0949170772.SGD","LU2637428348.USD","LU0545039389.USD","BK4208","LU2500361329.USD","BK4585","LU2346227817.USD","LU1894683348.USD","BK4588","LU1894683264.USD","CMS","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172522668","title":"新型气象站助力CMS能源提升抢修效率、强化安全保障并降低风暴成本","url":"https://stock-news.laohu8.com/highlight/detail?id=1172522668","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172522668?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:02","pubTimestamp":1776772951,"startTime":"0","endTime":"0","summary":"新型气象站的部署正为CMS能源公司带来多重效益,显著加快了电力恢复速度,同时增强了作业安全性并有效降低了风暴应对成本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","LU1003077747.HKD","LU2346227817.USD","LU2637428348.USD","LU0949170772.SGD","LU1894683264.USD","BK4585","LU0553294199.USD","BK4208","LU0661504455.SGD","LU1894683348.USD","CMS","BK4588","LU2500361329.USD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114411037","title":"财报前瞻|CMS能源本季度营收预计增12.04%,机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1114411037","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114411037?lang=zh_cn&edition=full","pubTime":"2026-04-21 10:05","pubTimestamp":1776737150,"startTime":"0","endTime":"0","summary":"CMS能源将于2026年04月28日盘前发布新财季业绩,市场普遍预期本季度核心指标同比增长,关注资本开支与电网可靠性投入的节奏与回报。市场一致预期显示,CMS能源本季度营收预计为25.07亿美元,同比增长12.04%;调整后每股收益预计为1.11美元,同比增长8.96%;息税前利润预计为5.85亿美元,同比增长16.87%。上季度公司营收为22.33亿美元,同比增长12.27%;毛利率40.84%;归属于母公司股东的净利润为2.89亿美元,净利率12.94%;调整后每股收益为0.94美元,同比增长8.05%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|CMS能源本季度营收预计增12.04%,机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622432688","title":"Anthropic最强模型曝光,性能实现“代际跃迁”,全面碾压Opus!","url":"https://stock-news.laohu8.com/highlight/detail?id=2622432688","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622432688?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:27","pubTimestamp":1774596464,"startTime":"0","endTime":"0","summary":"Anthropic一次低级配置失误,意外将最高机密推上风口浪尖——近3000份内部文件遭公开检索,揭露代号\"Capybara\"的旗舰新模型Claude Mythos已完成训练。该模型性能被内部定性为\"代际跃迁\",全面压制现有最强版本Opus 4.6,却因网络攻击能力\"远超任何现有AI\"而被束之高阁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768562","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMS","LU2637428348.USD","BK4023","BK4543","LU0553294199.USD","LU0661504455.SGD","LU1894683264.USD","AI","LU1894683348.USD","CHAT","AGIX","BK4585","BK4588","LU1003077747.HKD","BK4587","BK4208","LU2346227817.USD","BK4551","LU2500361329.USD","LU0545039389.USD","BK4528","VGT","LU0738911758.USD","LU0949170772.SGD","AIPO","AIYY","CIBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617334504","title":"康哲药业:INHBE小核酸药物CMS-D008临床试验获批治疗超重或肥胖","url":"https://stock-news.laohu8.com/highlight/detail?id=2617334504","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617334504?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:34","pubTimestamp":1772768040,"startTime":"0","endTime":"0","summary":"近日,康哲药业发布公告称,其自主研发的创新药INHBE小核酸药物CMS-D008于2026年3月4日获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物将用于超重或肥胖的临床试验。CMS-D008是一款皮下注射的siRNA药物,旨在通过靶向抑制肝脏的抑制素亚基βE基因表达,从而降低脂质堆积。全球超重和肥胖成年人的比例预计到2030年将达到50%,这为CMS-D008的市场前景提供了良好的基础。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-06/doc-inhpzkwr9288514.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-06/doc-inhpzkwr9288514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BMCWC346.EUR","00867","IE00BVYPNQ40.USD","CMS","BK4585","IE00BVYPNP33.GBP","LU0661504455.SGD","LU0949170772.SGD","LU0545039389.USD","BK1191","LU2637428348.USD","BK4588","LU1894683264.USD","LU1003077747.HKD","SG9999004220.SGD","SG9999015978.USD","BK1593","LU2500361329.USD","LU0738911758.USD","BK4208","LU2488822045.USD","SG9999015952.SGD","SG9999015986.USD","LU1894683348.USD","LU0553294199.USD","SG9999015945.SGD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","LU2346227817.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616253165","title":"康哲药业(00867):自主研发创新药INHBE小核酸药物CMS-D008获得超重或肥胖适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616253165","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616253165?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:58","pubTimestamp":1772621908,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 发布公告,本集团自主研发的创新药INHBE小核酸药物CMS-D008注射液于2026年3月4日获得中国国家药品监督管理局签发的药物临床试验批准通知书。NMPA同意开展CMS-D008注射液用于超重或肥胖的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BMCWC346.EUR","BK4588","LU0545039389.USD","06978","BK1191","00867","LU1894683264.USD","BK4208","LU2637428348.USD","BK1161","BK1593","LU2500361329.USD","LU1003077747.HKD","159992","LU1894683348.USD","SG9999015978.USD","IE00BVYPNQ40.USD","LU0553294199.USD","LU0949170772.SGD","SG9999004220.SGD","IE00BYV24P56.USD","LU2346227817.USD","SG9999015952.SGD","BK4585","IE00BGHQDM52.EUR","LU2488822045.USD","BK1574","SG9999015945.SGD","IE00BVYPNP33.GBP","LU0661504455.SGD","SG9999015986.USD","CMS","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616312803","title":"CMS暂停Elevance医保优势处方药计划的新成员注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2616312803","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616312803?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:19","pubTimestamp":1772453940,"startTime":"0","endTime":"0","summary":"一份文件显示,美国医疗保险和医疗补助服务中心(CMS)已通知Elevance Health保险公司,计划对其实施处罚,暂停该公司医保优势(Medicare Advantage)处方药计划的新成员招募。\n 除非监管机构认定相关问题已得到妥善解决,否则该处罚将于2026 年 3 月 31 日正式生效。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-02/doc-inhprfsk5148402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CMS","LU2637428348.USD","LU0661504455.SGD","LU0545039389.USD","BK4588","LU0553294199.USD","LU2346227817.USD","BK4208","BK4585","LU1003077747.HKD","LU1894683264.USD","LU1894683348.USD","LU2500361329.USD","LU0949170772.SGD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105964154","title":"数字解读可靠性路线图:客户投资驱动2025年实现2700项电力可靠性升级","url":"https://stock-news.laohu8.com/highlight/detail?id=1105964154","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105964154?lang=zh_cn&edition=full","pubTime":"2026-02-18 23:43","pubTimestamp":1771429401,"startTime":"0","endTime":"0","summary":"根据最新发布的可靠性路线图,CMS能源公司计划在2025年通过客户投资推动电力系统全面升级。该战略规划显示,将累计完成2700项电力可靠性改进工程,涵盖电网现代化改造、故障预警系统优化及应急响应机制强化等重点领域。这一系列技术升级将显著提升供电稳定性,降低平均停电频率,并为可再生能源大规模接入奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU0661504455.SGD","LU1894683264.USD","LU2500361329.USD","LU0738911758.USD","LU0949170772.SGD","LU0545039389.USD","BK4588","BK4208","LU1003077747.HKD","BK4585","LU1894683348.USD","CMS","LU2637428348.USD","LU2346227817.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129229500","title":"CMS能源:依据新招股说明书,约4.923亿美元总发行价股票仍可供发售——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1129229500","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129229500?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:25","pubTimestamp":1770848712,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会(SEC)的最新文件披露,CMS能源公司依据一份新的招股说明书,目前仍有总发行价格约为4.923亿美元的股票可供市场进行发售与认购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0738911758.USD","LU2346227817.USD","BK4588","LU0661504455.SGD","CMS","LU0545039389.USD","LU1003077747.HKD","LU0553294199.USD","LU1894683348.USD","LU2637428348.USD","BK4208","LU0949170772.SGD","BK4585","LU1894683264.USD","LU2500361329.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128789743","title":"CMS能源预计精选大型多年经济发展项目将于2026年启动加速——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1128789743","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128789743?lang=zh_cn&edition=full","pubTime":"2026-02-05 23:29","pubTimestamp":1770305353,"startTime":"0","endTime":"0","summary":"在最新电话会议中,CMS能源公司透露其精心挑选的大型多年期经济发展项目预计将从2026年开始逐步提升推进速度。这一战略规划标志着企业正为中长期增长注入新动能,通过系统性布局为区域经济与能源基础设施的协同发展铺平道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU0661504455.SGD","LU0949170772.SGD","LU1003077747.HKD","LU2637428348.USD","BK4585","LU2346227817.USD","BK4588","CMS","LU0738911758.USD","LU2500361329.USD","BK4208","LU0545039389.USD","LU1894683348.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179905585","title":"CMS能源大幅上调发电投资计划 较原方案增加约25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179905585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179905585?lang=zh_cn&edition=full","pubTime":"2026-02-05 23:13","pubTimestamp":1770304428,"startTime":"0","endTime":"0","summary":"在最新召开的投资者电话会议中,CMS能源公司宣布将大幅提升其发电领域资本开支规模。根据最新规划,该公司拟追加约25亿美元投资,这一数额显著超出了先前制定的预算方案。\n此次战略性增资将主要用于升级和扩建清洁能源发电设施,反映出公司加速向可持续能源转型的坚定承诺。管理层在会议中强调,这项投资计划旨在提升电网可靠性,同时满足密歇根州日益增长的电力需求。\n通过这项雄心勃勃的投资计划,CMS能源预计将显著提升其低碳发电能力,为未来业务增长奠定坚实基础。公司同时表示,该投资方案将遵循严格的资本配置原则,确保为股东创造长期价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0661504455.SGD","LU0553294199.USD","BK4585","LU0545039389.USD","LU0738911758.USD","LU1894683264.USD","LU2637428348.USD","BK4588","CMS","BK4208","LU1003077747.HKD","LU1894683348.USD","LU0949170772.SGD","LU2346227817.USD","LU2500361329.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147566149","title":"CMS能源第四季度调整后每股收益0.95美元 超出IBES预期0.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147566149","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147566149?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:47","pubTimestamp":1770292041,"startTime":"0","endTime":"0","summary":"CMS能源公司第四季度营收达22.33亿美元,大幅超越IBES机构此前预测的18.84亿美元。这一业绩表现凸显了公司在能源市场的强劲运营能力。\n在盈利指标方面,该公司当季调整后每股收益为0.95美元,较市场普遍预估的0.94美元实现小幅超预期。财务数据表明,CMS能源在控制成本和提升运营效率方面取得显著进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2500361329.USD","LU1894683264.USD","CMS","LU0661504455.SGD","LU1003077747.HKD","LU2637428348.USD","LU1894683348.USD","LU0949170772.SGD","LU2346227817.USD","LU0545039389.USD","LU0738911758.USD","BK4588","BK4208","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608795048","title":"康哲药业(00867)自主研发的创新药CMS-D017胶囊获得补体参与介导的肾脏疾病适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2608795048","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608795048?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:01","pubTimestamp":1770123674,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 公布,于2026年2月3日,集团自主研发的创新药CMS-D017胶囊获得中国国家药品监督管理局签发的药物临床试验批准通知书。CMS-D017通过靶向抑制补体因子B,阻止补体旁路途径的异常活化,减低膜攻击复合物对靶组织和器官的损伤,缓解补体失调相关疾病的进展。此前,CMS-D017拟用于治疗阵发性睡眠性血红蛋白尿症,已于2026年1月30日获得药物临床试验批准通知书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2637428348.USD","159992","LU2500361329.USD","CMS","00867","LU0545039389.USD","LU0661504455.SGD","LU0949170772.SGD","BK1191","SG9999015952.SGD","LU0738911758.USD","BK1161","LU1894683264.USD","IE00BVYPNP33.GBP","IE00BYV24P56.USD","BK4208","LU2346227817.USD","SG9999004220.SGD","06978","BK4585","BK1574","SG9999015978.USD","LU0553294199.USD","BK1593","LU1894683348.USD","SG9999015945.SGD","LU1003077747.HKD","BK4588","IE00BMCWC346.EUR","LU2488822045.USD","SG9999015986.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607014721","title":"康哲药业(00867):创新药补体因子B抑制剂CMS-D017 获得阵发性睡眠性血红蛋白尿症适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607014721","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607014721?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:25","pubTimestamp":1769772345,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 公布,于2026年1月30日,集团自主研发的创新药CMS-D017胶囊获得中国国家药品监督管理局签发的药物临床试验批准通知书。NMPA同意集团在中国健康参与者中开展评价CMS-D017安全性、耐受性、药代动力学和药效动力学特征的临床试验。CMS-D017是一种新型选择性补体因子B小分子抑制剂。CMS-D017在临床前研究中表现出优异的有效性和安全性,临床拟用于治疗阵发性睡眠性血红蛋白尿症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0949170772.SGD","159992","06978","IE00BVYPNP33.GBP","LU2637428348.USD","BK1191","BK1593","LU2500361329.USD","00867","LU2346227817.USD","SG9999015978.USD","SG9999004220.SGD","IE00BYV24P56.USD","BK4208","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","LU1894683264.USD","BK4588","LU0738911758.USD","LU0545039389.USD","SG9999015945.SGD","BK4585","LU0661504455.SGD","LU1003077747.HKD","IE00BVYPNQ40.USD","LU0553294199.USD","BK1574","LU1894683348.USD","SG9999015986.USD","CMS","IE00BGHQDM52.EUR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cmsenergy.com","stockEarnings":[{"period":"1week","weight":0.0434},{"period":"1month","weight":0.0263},{"period":"3month","weight":0.0021},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.0973},{"period":"ytd","weight":0.0938}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CMS Energy Corporation于1987年在密歇根州成立,是一家主要在该州内运营的能源公司。它是多家子公司的母公司控股公司,包括电力和燃气公用事业公司Consumers Energy,以及作为美国独立电力生产商和营销商运营的NorthStar Clean Energy。Consumers Energy为住宅、商业和工业客户提供电力和天然气服务,NorthStar Clean Energy则开发、运营和营销可再生能源和其他独立发电项目。CMS能源通过三个主要业务部门管理其运营:电力公用事业、燃气公用事业和NorthStar清洁能源,代表非公用事业运营和投资。消费者能源在CMS能源的总资产、收入、营业收入中占比较大。","yearOnYearQuotes":[{"month":1,"riseRate":0.521739,"avgChangeRate":0.014374},{"month":2,"riseRate":0.478261,"avgChangeRate":-0.007966},{"month":3,"riseRate":0.630435,"avgChangeRate":0.020056},{"month":4,"riseRate":0.531915,"avgChangeRate":0.004863},{"month":5,"riseRate":0.586957,"avgChangeRate":0.012572},{"month":6,"riseRate":0.531915,"avgChangeRate":-0.00068},{"month":7,"riseRate":0.478261,"avgChangeRate":-0.009134},{"month":8,"riseRate":0.586957,"avgChangeRate":0.011565},{"month":9,"riseRate":0.5,"avgChangeRate":-0.012171},{"month":10,"riseRate":0.586957,"avgChangeRate":0.008128},{"month":11,"riseRate":0.608696,"avgChangeRate":0.015274},{"month":12,"riseRate":0.630435,"avgChangeRate":0.016936}],"exchange":"NYSE","name":"CMS能源","nameEN":"CMS Energy Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CMS能源(CMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CMS能源(CMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CMS能源,CMS,CMS能源股票,CMS能源股票老虎,CMS能源股票老虎国际,CMS能源行情,CMS能源股票行情,CMS能源股价,CMS能源股市,CMS能源股票价格,CMS能源股票交易,CMS能源股票购买,CMS能源股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CMS能源(CMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CMS能源(CMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}